Florida Administrative Code
59 - AGENCY FOR HEALTH CARE ADMINISTRATION
59A - Health Facility and Agency Licensing
Chapter 59A-11 - BIRTH CENTER STANDARDS AND LICENSURE
Section 59A-11.016 - Postpartum Care
Current through Reg. 50, No. 187; September 24, 2024
(1) A cord blood sample shall be secured for laboratory testing for type, Rh determination, and direct Coombs test when the mother is Rh negative.
(2) The newborn shall be weighed, measured, inspected for abnormalities and examined for complications. An identification tape shall be placed on the newborn if more than one newborn is at the center at the same time.
(3) One half milligram of Vitamin K shall be administered to the newborn within 24 hours after birth. If no one on the birth center staff is licensed to administer this medication, the parents shall be instructed to take the infant to a private physician or clinic for the injection.
(4) The newborn shall be referred to physician or hospital care if the following conditions occur:
(5) The condition of the mother shall be monitored frequently to detect signs of hemorrhage, or other complications, requiring prompt transfer to a physician or hospital.
(6) The mother and infant shall be discharged from the birth center within 24 hours after the birth occurs except under the following conditions:
(7) If the mother, or infant, is retained at the birth center longer than 24 hours after birth, except as identified in paragraphs 59A-11.016(6)(a) and (b), F.A.C., a report shall be filed with the local county public health unit within 48 hours after the birth describing the circumstances and reasons for the decision.
(8) A postpartum examination shall be performed within 72 hours after delivery and at approximately four to six weeks after delivery.
(9) The mother shall be counseled regarding breast feeding, perineal care, family planning, signs of common complications, postpartum depression including the provision of the telephone number of the Family Health Line operated pursuant to Section 383.011, F.S., activities and exercises, sex relations, care and feeding of the newborn, and changing family relationships.
(10) The metabolic screening test shall be performed on the newborn in accordance with Section 383.14, F.S.
(11) The parents shall be referred to providers of pediatric care and instructed about immunization.
(12) If complications in the mother or newborn occur during the postpartum period, a consultation or referral shall be made to the appropriate source of secondary or tertiary care.
(13) If the mother refuses to permit eye prophylaxis on account of religious beliefs contrary to the use of drugs, Vitamin K injection, or metabolic screening test, a waiver indicating this decision shall be signed by the mother, witnessed by a clinical staff member, and filed with the clinical record.
(14) Infant (postnatal) screening shall be offered and documented in accordance with the following statute and rule administered by the Department of Health: Section 383.14, F.S. and Chapter 64C-7, F.A.C.
Rulemaking Authority 383.309 FS. Law Implemented 383.318 FS.
New 3-4-85, Formerly 10D-90.16, 10D-90.016, Amended 9-27-94, 2-12-96, 1-16-19.